TPCW
TD Private Client Wealth Portfolio holdings
AUM
$4.07B
1-Year Return
14.25%
This Quarter Return
+1.55%
1 Year Return
+14.25%
3 Year Return
+49.74%
5 Year Return
+85.19%
10 Year Return
–
AUM
$3.18B
AUM Growth
+$129M
(+4.2%)
Cap. Flow
+$96.8M
Cap. Flow
% of AUM
3.05%
Top 10 Holdings %
Top 10 Hldgs %
33.87%
Holding
1,277
New
61
Increased
526
Reduced
484
Closed
61
Top Buys
| 1 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$23.1M |
| 2 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
$21.2M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
$14.5M |
| 4 |
iShares US Treasury Bond ETF
GOVT
|
$7.02M |
| 5 |
Vanguard Short-Term Treasury ETF
VGSH
|
$5.91M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$5.93M |
| 2 |
Eli Lilly
LLY
|
$4.41M |
| 3 |
Visa
V
|
$3.17M |
| 4 |
NVIDIA
NVDA
|
$2.95M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
$2.62M |
Sector Composition
| 1 | Technology | 8.27% |
| 2 | Financials | 4.79% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 3.32% |
| 5 | Communication Services | 2.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Trimble
TRMB
$19.2B
| $4.03K | ﹤0.01% |
72
-18
| -20% | -$1.01K |
|
1102
Invesco Emerging Markets Sovereign Debt ETF
PCY
$1.24B
| $4K | ﹤0.01% |
200
+74
| +59% | +$1.48K |
|
1103
Certara
CERT
$1.69B
| $3.96K | ﹤0.01% |
286
+70
| +32% | +$969 |
|
1104
iShares MSCI Japan ETF
EWJ
$15.5B
| $3.96K | ﹤0.01% |
58
| – | – |
|
1105
Chemours
CC
$2.34B
| $3.84K | ﹤0.01% |
170
| – | – |
|
1106
Hormel Foods
HRL
$14.1B
| $3.63K | ﹤0.01% |
119
+92
| +341% | +$2.81K |
|
1107
Darling Ingredients
DAR
$5.07B
| $3.6K | ﹤0.01% |
98
-237
| -71% | -$8.71K |
|
1108
Lincoln National
LNC
$7.98B
| $3.51K | ﹤0.01% |
113
| – | – |
|
1109
Incyte
INCY
$16.9B
| $3.33K | ﹤0.01% |
55
-292
| -84% | -$17.7K |
|
1110
Kite Realty
KRG
$5.11B
| $3.31K | ﹤0.01% |
148
| – | – |
|
|
CMBT
1111
CMB.TECH NV
CMBT
$2.64B
| $3.28K | ﹤0.01% |
198
| – | – |
|
1112
Lloyds Banking Group
LYG
$64.5B
| $3.22K | ﹤0.01% |
1,178
+701
| +147% | +$1.91K |
|
|
CERE
1113
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $3.19K | ﹤0.01% |
+78
| New | +$3.19K |
|
1114
Texas Roadhouse
TXRH
$11.2B
| $3.09K | ﹤0.01% |
18
+7
| +64% | +$1.2K |
|
1115
AB InBev
BUD
$118B
| $3.08K | ﹤0.01% |
53
+27
| +104% | +$1.57K |
|
1116
Takeda Pharmaceutical
TAK
$48.6B
| $3.08K | ﹤0.01% |
238
+123
| +107% | +$1.59K |
|
1117
Azenta
AZTA
$1.39B
| $2.89K | ﹤0.01% |
55
-89
| -62% | -$4.68K |
|
1118
ORIX
IX
$29.3B
| $2.89K | ﹤0.01% |
130
+75
| +136% | +$1.67K |
|
1119
Freshpet
FRPT
$2.7B
| $2.85K | ﹤0.01% |
22
-3
| -12% | -$388 |
|
1120
Omega Healthcare
OHI
$12.7B
| $2.77K | ﹤0.01% |
81
| – | – |
|
1121
Teva Pharmaceuticals
TEVA
$21.7B
| $2.71K | ﹤0.01% |
167
+133
| +391% | +$2.16K |
|
1122
SPDR Dow Jones Global Real Estate ETF
RWO
$1.14B
| $2.66K | ﹤0.01% |
64
| – | – |
|
1123
Vanguard World Funds Extended Duration ETF
EDV
$3.64B
| $2.64K | ﹤0.01% |
36
| – | – |
|
1124
Deutsche Bank
DB
$67.8B
| $2.61K | ﹤0.01% |
164
+124
| +310% | +$1.98K |
|
1125
Barclays
BCS
$69.1B
| $2.49K | ﹤0.01% |
232
+159
| +218% | +$1.7K |
|